CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 475 of 749 entries

View as:

Response of Cardiometabolic Biomarkers and Gut Microbiota to Walnut Consumption

Phase: N/A Priority: Normal

NCT ID: NCT05321277 Org: User:

Start: 04/19/22 End: 08/31/25 Due: 08/31/26

Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms

Phase: N/A Priority: Normal

NCT ID: NCT01110174 Org: User:

Start: 03/31/10 End: 03/31/16 Due: 03/31/17

Development of a Marker of Adherence for Tracking Consumption of Nutrient Supplements

Phase: N/A Priority: Normal

NCT ID: NCT04040543 Org: User:

Start: 07/26/19 End: 11/30/20 Due: 11/30/21

Feasibility of a Non-invasive, Trans-abdominal, Low Cost Fetal Oximetry Probe on Pregnant Human Subjects

Phase: N/A Priority: Normal

NCT ID: NCT03013842 Org: User:

Start: 12/12/16 End: 08/02/17 Due: 08/02/18

Nitrosomonas Eutropha on Nitrolipids in the Skin

Phase: N/A Priority: Normal

NCT ID: NCT02938650 Org: User:

Start: 10/31/16 End: 05/31/17 Due: 05/31/18

Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents

Phase: N/A Priority: Normal

NCT ID: NCT03199716 Org: User:

Start: 09/30/14 End: 03/23/17 Due: 03/23/18

Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache

Phase: N/A Priority: Normal

NCT ID: NCT06621329 Org: User:

Start: 10/17/24 End: 10/31/26 Due: 10/31/27

Endoscopic Subsurface Optical Imaging for Cancer Detection

Phase: N/A Priority: Normal

NCT ID: NCT01810445 Org: User:

Start: 01/31/99 End: 08/31/11 Due: 08/31/12

Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light

Phase: N/A Priority: Normal

NCT ID: NCT05865431 Org: User:

Start: 03/17/17 End: 02/02/18 Due: 02/02/19

Effectiveness Study of Videoconferencing on Teaching Parent Training Skills to Parents of Children With Attention Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal

NCT ID: NCT01161719 Org: User:

Start: 04/30/08 End: 06/30/09 Due: 06/30/10

Comparison of Preoperative Ultrasound Guided Pectoralis Nerve Block Placement Versus Intra-operative Placement: A Prospective Randomized Trial

Phase: N/A Priority: Normal

NCT ID: NCT03201809 Org: User:

Start: 09/01/16 End: 03/23/20 Due: 03/23/21

Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)

Phase: N/A Priority: Normal

NCT ID: NCT00574184 Org: User:

Start: 08/31/05 End: 03/31/08 Due: 03/31/09

Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis

Phase: N/A Priority: Normal

NCT ID: NCT00368719 Org: User:

Start: 09/30/07 End: 07/31/16 Due: 07/31/17

Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides

Phase: N/A Priority: Normal

NCT ID: NCT03526081 Org: User:

Start: 01/20/15 End: 07/30/16 Due: 07/30/17

Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)

Phase: N/A Priority: Normal

NCT ID: NCT06252727 Org: User:

Start: 07/31/24 End: 05/31/26 Due: 05/31/27

Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris

Phase: N/A Priority: Normal

NCT ID: NCT02905851 Org: User:

Start: 05/31/16 End: 05/31/18 Due: 05/31/19

Correlation of Molecular Biomarkers With Biopsy Findings and Outcomes in Renal Transplant Recipients

Phase: N/A Priority: Normal

NCT ID: NCT02463253 Org: User:

Start: 04/30/15 End: 05/31/16 Due: 05/31/17

CCRC: Understanding the Effects of Omega-3 Fatty Acids Versus Lignans in Flaxseed on Metabolic and Inflammatory Markers Leading to Diabetes and Cardiovascular Disease

Phase: N/A Priority: Normal

NCT ID: NCT00935922 Org: User:

Start: 02/28/09 End: 04/30/10 Due: 04/30/11

Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers

Phase: N/A Priority: Normal

NCT ID: NCT00619645 Org: User:

Start: 06/30/07 End: 11/30/13 Due: 11/30/14

Genetic Basis of Melanocytic Nevi

Phase: N/A Priority: Normal

NCT ID: NCT03054584 Org: User:

Start: 06/26/17 End: 06/30/25 Due: 06/30/26

Effects of Vaporized Marijuana on Neuropathic Pain

Phase: N/A Priority: Normal

NCT ID: NCT01037088 Org: User:

Start: 12/31/09 End: 11/30/12 Due: 11/30/13

Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event

Phase: N/A Priority: Normal

NCT ID: NCT01820234 Org: User:

Start: 09/30/10 End: 06/30/11 Due: 06/30/12

CPAP to Improve Swallow Function Post Total Laryngectomy

Phase: N/A Priority: Normal

NCT ID: NCT03328702 Org: User:

Start: 06/27/16 End: 11/08/22 Due: 11/08/23

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Phase: N/A Priority: Normal

NCT ID: NCT06101290 Org: User:

Start: 10/05/23 End: 01/05/31 Due: 01/05/32

Enhancing Lung Cancer Screening Through Human-Centered Intervention

Phase: N/A Priority: Normal

NCT ID: NCT06351085 Org: User:

Start: 11/10/22 End: 04/14/25 Due: 04/14/26

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Response of Cardiometabolic Biomarkers and Gut Microbiota to Walnut Consumption	NCT05321277	University of California, Davis	user2@example.com	None	2022-04-19	2025-08-31	2026-08-31	-	-	2025-07-14
Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms	NCT01110174	University of California, Davis	user2@example.com	None	2010-03-31	2016-03-31	2017-03-31	-	-	2025-07-14
Development of a Marker of Adherence for Tracking Consumption of Nutrient Supplements	NCT04040543	University of California, Davis	user2@example.com	None	2019-07-26	2020-11-30	2021-11-30	-	-	2025-07-14
Feasibility of a Non-invasive, Trans-abdominal, Low Cost Fetal Oximetry Probe on Pregnant Human Subjects	NCT03013842	University of California, Davis	user2@example.com	None	2016-12-12	2017-08-02	2018-08-02	-	-	2025-07-14
Nitrosomonas Eutropha on Nitrolipids in the Skin	NCT02938650	University of California, Davis	user2@example.com	None	2016-10-31	2017-05-31	2018-05-31	-	-	2025-07-14
Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents	NCT03199716	University of California, Davis	user2@example.com	None	2014-09-30	2017-03-23	2018-03-23	-	-	2025-07-14
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache	NCT06621329	University of California, Davis	user2@example.com	None	2024-10-17	2026-10-31	2027-10-31	-	-	2025-07-14
Endoscopic Subsurface Optical Imaging for Cancer Detection	NCT01810445	University of California, Davis	user2@example.com	None	1999-01-31	2011-08-31	2012-08-31	-	-	2025-07-14
Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light	NCT05865431	University of California, Davis	user2@example.com	None	2017-03-17	2018-02-02	2019-02-02	-	-	2025-07-14
Effectiveness Study of Videoconferencing on Teaching Parent Training Skills to Parents of Children With Attention Deficit Hyperactivity Disorder (ADHD)	NCT01161719	University of California, Davis	user2@example.com	None	2008-04-30	2009-06-30	2010-06-30	-	-	2025-07-14
Comparison of Preoperative Ultrasound Guided Pectoralis Nerve Block Placement Versus Intra-operative Placement: A Prospective Randomized Trial	NCT03201809	University of California, Davis	user2@example.com	None	2016-09-01	2020-03-23	2021-03-23	-	-	2025-07-14
Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)	NCT00574184	University of California, Davis	user2@example.com	None	2005-08-31	2008-03-31	2009-03-31	-	-	2025-07-14
Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis	NCT00368719	University of California, Davis	user2@example.com	None	2007-09-30	2016-07-31	2017-07-31	-	-	2025-07-14
Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides	NCT03526081	University of California, Davis	user2@example.com	None	2015-01-20	2016-07-30	2017-07-30	-	-	2025-07-14
Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)	NCT06252727	University of California, Davis	user2@example.com	None	2024-07-31	2026-05-31	2027-05-31	-	-	2025-07-14
Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris	NCT02905851	University of California, Davis	user2@example.com	None	2016-05-31	2018-05-31	2019-05-31	-	-	2025-07-14
Correlation of Molecular Biomarkers With Biopsy Findings and Outcomes in Renal Transplant Recipients	NCT02463253	University of California, Davis	user2@example.com	None	2015-04-30	2016-05-31	2017-05-31	-	-	2025-07-14
CCRC: Understanding the Effects of Omega-3 Fatty Acids Versus Lignans in Flaxseed on Metabolic and Inflammatory Markers Leading to Diabetes and Cardiovascular Disease	NCT00935922	University of California, Davis	user2@example.com	None	2009-02-28	2010-04-30	2011-04-30	-	-	2025-07-14
Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers	NCT00619645	University of California, Davis	user2@example.com	None	2007-06-30	2013-11-30	2014-11-30	-	-	2025-07-14
Genetic Basis of Melanocytic Nevi	NCT03054584	University of California, Davis	user2@example.com	None	2017-06-26	2025-06-30	2026-06-30	-	-	2025-07-14
Effects of Vaporized Marijuana on Neuropathic Pain	NCT01037088	University of California, Davis	user2@example.com	None	2009-12-31	2012-11-30	2013-11-30	-	-	2025-07-14
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event	NCT01820234	University of California, Davis	user2@example.com	None	2010-09-30	2011-06-30	2012-06-30	-	-	2025-07-14
CPAP to Improve Swallow Function Post Total Laryngectomy	NCT03328702	University of California, Davis	user2@example.com	None	2016-06-27	2022-11-08	2023-11-08	-	-	2025-07-14
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)	NCT06101290	University of California, Davis	user2@example.com	None	2023-10-05	2031-01-05	2032-01-05	-	-	2025-07-14
Enhancing Lung Cancer Screening Through Human-Centered Intervention	NCT06351085	University of California, Davis	user2@example.com	None	2022-11-10	2025-04-14	2026-04-14	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance